verified SJR 0,795 · Q2 • database Scopus / SJR & Web of Science & DOAJ indexed

United States · John Wiley and Sons Inc

workspace_premium Q2 — Medicine (miscellaneous) visibility_off Single blind Peer Review lock_open Open Access · DOAJ

Thoracic Cancer

Thoracic Cancer is a journal indexed in SJR in Medicine (miscellaneous) and Oncology with an H index of 55. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 1800 €. The scope of the journal is focused on treatment and research, Asia-Pacific, thoracic cancer, prevention. It has an SJR impact factor of 0,795 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,795.

ISSN: 1759-7706

Publisher: John Wiley and Sons Inc

Category: Medicine (miscellaneous)

Indexation: verifiedScopus / SJR verifiedWeb of Science verifiedDOAJ

open_in_new Portal NPD menu_book Author guidelines

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,795 Q2

H-index 55

Acceptance rate pie_chart

34%

Source Acceptance_Rate

Time to publication hourglass_top

41 weeks

Field Average_time_publication_weeks

Publication cost (APC) payments

1.800 € Open Access

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science DOAJ

SJR Impact

0,795

H-index

Docs (year)

286

Docs 3y

1311

Total refs

8484

Cites 3y

3250

Citable 3y

1262

Cites/Doc 2y

2.41

Ref/Doc

29.66

Immediate OA

1800 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Clinical application of photodynamic therapy for malignant airway tumors in China

Well-controlled pleural effusion indicated pseudoprogression after immunotherapy in lung cancer: A case report

Differential diagnosis and cancer staging of a unique case with multiple nodules in the lung - lung adenocarcinoma, metastasis of colon adenocarcinoma, and colon adenocarcinoma metastasizing to lung adenocarcinoma

Diagnosis of the invasiveness of lung adenocarcinoma manifesting as ground glass opacities on high-resolution computed tomography

Delayed pseudoprogression of lung adenocarcinoma accompanied with interstitial lung disease during chemotherapy after nivolumab treatment

Current small cell lung cancer treatment in China

Comparison study of computed tomography-guided radiofrequency and microwave ablation for pulmonary tumors: A retrospective, case-controlled observational study

Comparison and discussion of the treatment guidelines for small cell lung cancer

Comparative study on the mutational profile of adenocarcinoma and squamous cell carcinoma predominant histologic subtypes in Chinese non-small cell lung cancer patients

Clinicopathological characteristics and prognostic factors of pulmonary large cell neuroendocrine carcinoma: A large population-based analysis

Clinical experiences with molecular targeted therapy in lung cancer in China

Clinical diagnosis and treatment of immune checkpoint inhibitor-associated pneumonitis

SHOW MORE ARTICLES

Clinical characteristics of the mixed form of neuroendocrine tumor in the lung: A retrospective study in 2501 lung cancer cases

A randomized clinical study to compare intrapleural infusion with intravenous infusion of bevacizumab in the management of malignant pleural effusion in patients with non-small-cell lung cancer

Circulating tumor cells in the pulmonary vein increase significantly after lobectomy: A prospective observational study

Circulating plasma lncRNAs as novel markers of

Circular RNA: The main regulator of energy metabolic reprogramming in cancer cells

Characterization of solitary pulmonary nodules using double phase Tc-99m methoxyisobutylisonitrile scan: Comparison of visual and quantitative analyses

Bioinformatics analysis and expression study of fumarate hydratase in lung cancer

APC

Anti-apoptotic brain and reproductive organ-expressed proteins enhance cisplatin resistance in lung cancer cells via the protein kinase B signaling pathway

Analysis of lung tumor initiation and progression in transgenic mice for Cre-inducible overexpression of Cul4A gene

Amrubicin monotherapy for elderly patients with relapsed extensive-disease small-cell lung cancer: A retrospective study

Alternative method for jejunostomy in Ivor-Lewis esophagectomy

FAQs

Thoracic Cancer has an SJR of 0,795 (best quartile Q2) in the CountryOfPapers database.

Immediate OA APC is 1800 EUR.

The acceptance rate recorded for Thoracic Cancer is 34%.

Thoracic Cancer

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Thoracic Cancer?

What is the APC / publication cost?

What is the acceptance rate?